122 related articles for article (PubMed ID: 5917090)
1. Carbamylation and binding constants for the inhibition of acetylcholinesterase by physostigmine (eserine).
Main AR; Hastings FL
Science; 1966 Oct; 154(3747):400-2. PubMed ID: 5917090
[TBL] [Abstract][Full Text] [Related]
2. Acetylcholinesterase inhibition by eserine: rate constants of reaction. Part II.
Brufani M; Lippa S; Marta M; Oradei A; Pomponi M
Ital J Biochem; 1985; 34(5):328-40. PubMed ID: 4077467
[TBL] [Abstract][Full Text] [Related]
3. An investigation of the in vitro inhibition of acetylcholinesterase by the carbamate inhibitor eserine sulphate in eserine resistant strains of Drosophila melanogaster.
Burnell AM; Wilkins NP
Comp Biochem Physiol C Comp Pharmacol Toxicol; 1988; 90(1):215-20. PubMed ID: 2904861
[TBL] [Abstract][Full Text] [Related]
4. Rate constants of carbamylation and decarbamylation of acetylcholinesterase for physostigmine and carbaryl in the presence of an oxime.
Dawson RM
Neurochem Int; 1994 Feb; 24(2):173-82. PubMed ID: 8161944
[TBL] [Abstract][Full Text] [Related]
5. A new simple method for determining the kinetic constants of inhibited acetylcholinesterase.
Brufani M; Lippa S; Littarru GP; Oradei A; Pomponi M
Ital J Biochem; 1984; 33(5):325-32. PubMed ID: 6511307
[TBL] [Abstract][Full Text] [Related]
6. Substrate and dilution effects on the inhibition of acetylcholinesterase by carbamates.
Winteringham FP; Fowler KS
Biochem J; 1966 Oct; 101(1):127-34. PubMed ID: 5971773
[TBL] [Abstract][Full Text] [Related]
7. Kinetic characterization of all steps of the interaction between acetylcholinesterase and eserine.
Stojan J; Zorko M
Biochim Biophys Acta; 1997 Jan; 1337(1):75-84. PubMed ID: 9003439
[TBL] [Abstract][Full Text] [Related]
8. Kinetic investigations into the interactions of aprophen with cholinesterases and a carboxylesterase.
Rush RS; Doctor BP; Wolfe AD
Biochem Pharmacol; 1986 Dec; 35(23):4167-70. PubMed ID: 3098245
[TBL] [Abstract][Full Text] [Related]
9. Mechanism of eserine action on the hydrolysis of butyrylthiocholine by butyrylcholinesterase.
Stojan J; Pavlic MR
J Enzyme Inhib; 1997 Jan; 11(3):199-208. PubMed ID: 9204388
[TBL] [Abstract][Full Text] [Related]
10. Noncompetitive inhibition of acetylcholinesterase by eserine.
Stein HH; Lewis GJ
Biochem Pharmacol; 1969 Jul; 18(7):1679-84. PubMed ID: 5806108
[No Abstract] [Full Text] [Related]
11. Transient kinetic approach to the study of acetylcholinesterase reversible inhibition by eseroline.
Golicnik M; Stojan J
J Enzyme Inhib Med Chem; 2002 Oct; 17(5):279-85. PubMed ID: 12683744
[TBL] [Abstract][Full Text] [Related]
12. A theoretical kinetic analysis of the protective action exerted by eserine and other carbamate anticholinesterases against poisoning by organophosphorus compounds.
Green AL
Biochem Pharmacol; 1983 Jun; 32(11):1717-22. PubMed ID: 6870912
[TBL] [Abstract][Full Text] [Related]
13. Physostigmine analogs anticholinesterases: effects of the lengthening of the N-carbamic chain on the inhibition kinetics.
Marta M; Gatta F; Pomponi M
Biochim Biophys Acta; 1992 Apr; 1120(3):262-6. PubMed ID: 1576152
[TBL] [Abstract][Full Text] [Related]
14. Oxime effects on the rate constants of carbamylation and decarbamylation of acetylcholinesterase for pyridostigmine, physostigmine and insecticidal carbamates.
Dawson RM
Neurochem Int; 1995 Jun; 26(6):643-54. PubMed ID: 7670367
[TBL] [Abstract][Full Text] [Related]
15. Acetylcholinesterase. II. A study by nuclear magnetic resonance of the acceleration of acetylcholinesterase by atropine and inhibition by eserine.
Kato G
Mol Pharmacol; 1972 Sep; 8(5):582-8. PubMed ID: 5083615
[No Abstract] [Full Text] [Related]
16. Long chain analogs of physostigmine as potential drugs for Alzheimer's disease: new insights into the mechanism of action in the inhibition of acetylcholinesterase.
Perola E; Cellai L; Lamba D; Filocamo L; Brufani M
Biochim Biophys Acta; 1997 Nov; 1343(1):41-50. PubMed ID: 9428657
[TBL] [Abstract][Full Text] [Related]
17. A new method to characterize the kinetics of cholinesterases inhibited by carbamates.
Xiao Q; Zhou H; Wei H; Du H; Tan W; Zhan Y; Pistolozzi M
J Pharm Biomed Anal; 2017 Sep; 144():175-182. PubMed ID: 28483282
[TBL] [Abstract][Full Text] [Related]
18. Microcalorimetric study of the inhibition of butyrylcholinesterase by carbamates.
Debord J; Laubarie C; Dantoine T
Anal Biochem; 2008 Feb; 373(2):247-52. PubMed ID: 17950687
[TBL] [Abstract][Full Text] [Related]
19. Kinetics of human erythrocyte acetylcholinesterase inhibition by a novel derivative of physostigmine: phenserine.
al-Jafari AA; Kamal MA; Greig NH; Alhomida AS; Perry ER
Biochem Biophys Res Commun; 1998 Jul; 248(1):180-5. PubMed ID: 9675107
[TBL] [Abstract][Full Text] [Related]
20. Kinetic analysis of the protection afforded by reversible inhibitors against irreversible inhibition of acetylcholinesterase by highly toxic organophosphorus compounds.
Eckert S; Eyer P; Mückter H; Worek F
Biochem Pharmacol; 2006 Jul; 72(3):344-57. PubMed ID: 16780806
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]